SCHEMBL31494410

SCHEMBL31494410

Cc1cc(N)nc(SCc2nc(C(C)(C)C)no2)n1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 4/20 0.52
▸ NPC1 O15118 2/20 0.52
▸ SMN1; SMN2 Q16637 2/20 0.52
▸ LMNA P02545 2/20 0.52
▸ HTT P42858 2/20 0.52
▸ ALDH1A1 P00352 4/20 0.38
▸ ATM Q13315 1/20 0.38
▸ TSHR P16473 2/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ HPGD P15428 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ DCK P27707 1/20 0.33
▸ PKM P14618 1/20 0.33
▸ PIK3CG P48736 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27218777 0.88 RAB9A (0.48) RAB9ANPC1SMN1; SMN2LMNAHTT
SCHEMBL27218708 0.79 RAB9A (0.49) RAB9ANPC1SMN1; SMN2LMNAHTT
SCHEMBL29808161 0.77 ALOX15 (0.43) RAB9ANPC1SMN1; SMN2LMNAHTT
SCHEMBL27218745 0.77 RAB9A (0.50) RAB9ANPC1SMN1; SMN2LMNAHTT
SCHEMBL27218748 0.77 RAB9A (0.50) RAB9ANPC1SMN1; SMN2LMNAHTT
SCHEMBL31528335 0.77 RAB9A (0.50) RAB9ANPC1SMN1; SMN2LMNAHTT
SCHEMBL27218817 0.77 RAB9A (0.50) RAB9ANPC1SMN1; SMN2LMNAHTT
SCHEMBL31494430 0.76 SMN1; SMN2 (0.72) RAB9ANPC1SMN1; SMN2LMNAHTT
SCHEMBL31494451 0.75 RAB9A (0.48) RAB9ANPC1SMN1; SMN2LMNAHTT
SCHEMBL27218886 0.75 SMN1; SMN2 (0.70) RAB9ANPC1SMN1; SMN2LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4232448-B1 AGONISTS OF FREE FATTY ACID RECEPTOR 1 AND THEIR USE IN DISEASES ASSOCIATED WITH SAID RECEPTOR Halo Therapeutics Ltd (GB) 2025-05-07 — — EP disclosed
EP-3956323-B1 OXAZOLE AND OXADIAZOLE DERIVATIVES USEFUL AS AGONISTS OF FREE FATTY ACID RECEPTOR 1 Halo Therapeutics Ltd (GB) 2025-03-05 — — EP disclosed
Send feedback